KLK3 and prostate carcinoma: Prostate-specific antigen tests for prostate cancer are burdened by substantial false-positive (21% to 32% sensitivity) and false-negative rates (85% to 91% specificity).45 In contrast, serum testing for MGUS is straightforward.